← EPO Patent Bulletin

IL-17A ANTIBODY FORMULATION AND USE THEREOF

Publication EP4631522A1 Kind: A1 Mar 18, 2026

Applicants

Shanghai Huaota Biopharmaceutical Co., Ltd., Huabo Biopharm (Shanghai) Co., Ltd.

Inventors

JIA, Huifeng, PAN, Xianfei, WANG, Shaojie, CUI, Xiaopei, ZHU, Xiangyang

IPC Classifications

A61K 39/395 20060101AFI20240614BHEP A61K 9/19 20060101ALI20240614BHEP A61K 47/12 20060101ALI20240614BHEP A61K 47/26 20060101ALI20240614BHEP C07K 16/24 20060101ALI20240614BHEP A61P 19/02 20060101ALI20240614BHEP A61P 19/08 20060101ALI20240614BHEP A61P 1/00 20060101ALI20240614BHEP A61P 3/10 20060101ALI20240614BHEP A61P 17/06 20060101ALI20240614BHEP A61P 29/00 20060101ALI20240614BHEP A61P 37/02 20060101ALI20240614BHEP A61P 25/00 20060101ALI20240614BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR